NK cells are key players in the fight against persistent viruses. Human cytomegalovirus (HCMV) infection is associated with the presence of a population of CD16
Introduction
Natural killer (NK) cells are a subset of lymphocytes comprising 5-20% of peripheral blood mononuclear cells (PBMCs) in cytokine-mediated immune-modulatory role [3] . Furthermore, a scarce subset of NK cells, devoid of CD56 expression and displaying a reduced functional capacity, has been identified in healthy controls [4] and in chronic viral infections [5] [6] [7] .
The contribution of NK cells to the antiviral immune response has been extensively studied in murine viral infections, demonstrating that NK cells impede viral replication [8, 9] . In humans, rare NK-cell deficiencies have established the critical role of functional NK cells in the control of human viral infections, in particular toward herpesviruses [10, 11] .
Human cytomegalovirus (HCMV) chronically infects 50-90% of humans. HCMV is usually acquired early in life, and most immunocompetent hosts are asymptomatic. However, HCMV can cause severe disease in immunocompromised individuals, such as HIV-seropositive patients and transplant recipients on immunosuppressive therapy, resulting from the reactivation of latent infection. Furthermore, maternal HCMV reactivation or primary infection (PI) during pregnancy can result in the infection of the fetus. HCMV is the most common cause of congenital infection and is associated with long-term sequelae [12] .
An effective defense against HCMV requires the participation of innate and adaptive immunity with a central role for NK cells and T lymphocytes. Although primary HCMV infection of immunocompetent subjects is usually subclinical, chronic infection is associated with an age-related deterioration of the immune system, in particular with (i) the accumulation of late differentiated and oligoclonal CD8
+ T-cell populations (referred to as memory inflation) [13, 14] , (ii) an exhaustion of immune resources [15] , and (iii) the development of an "immune risk phenotype" that is predictive of early mortality in the elderly [16, 17] . CMV also has an impact on NK cells. In MCMV infection, a specific population of NK cells expands, contracts after viral control, and generates long-lived "memory" NK cells expressing Ly49H that are more protective during a second encounter with MCMV [9, 18] . Looking at the impact of other herpesviruses to induce late differentiated NK cells either during the acute phase of symptomatic EBV-induced mononucleosis [19] or during recurrent HSV-2 infection [20] , recent studies did not find any expansion of NK cells expressing the activating receptor NKG2C. Other publications have described the expansion of NKG2C + NK cells following infections with Hantavirus [21] and Chikungunya virus [22] , but only in patients chronically infected with HCMV. These findings are in line with several studies that consistently describe the expansion of NKG2C + NK cells in response to HCMV [23] [24] [25] [26] [27] [28] .
Considering that HCMV infection contributes to age-associated changes in adaptive immunity and that aging also affects the distribution of NK cells [29, 30] , we have investigated the possible contribution of HCMV at the different phases of infection to the age-associated alterations in NK-cell subsets. For this purpose, we used patient samples from different clinical settings where both age and CMV events could be dissected: (i) healthy volunteers of different age (long-term carriers of HCMV or uninfected), (ii) CMV-seronegative women who acquire primary HCMV-infection during pregnancy, (iii) lung transplant adults who suffer or not from HCMV reactivations posttransplantation, and (iv) young adults thymectomized in early life for whom adaptive immunity exhibits signs of premature immune aging. By looking at both innate and adaptative HCMV-induced responses simultaneously, we have drawn a parallel between the impact of HCMV on the composition of highly differentiated T-cell and NK-cell subsets in human.
Results

Effect of age on human NK-cell properties
We analyzed the phenotype of CD16 + CD56 dim NK cells in more than a hundred healthy donors stratified according to their age. Subject information (age, gender, and HCMV status) is provided in Table 1 . While we observed a big heterogeneity in the CD16 + CD56 dim absolute counts in each group, no statistical differences were observed between young, middle-aged, and elderly adults in concordance with previous observations [29, 31] . We thus divided the CD16 + CD56 dim NK-cell population into three distinct subsets based on the expression of NKG2A, NKG2C, and CD57, as illustrated in Figure 1A , and referred to as: early (NKG2A Supporting Information 1A and C, respectively) were significantly higher in older people (Kruskal-Wallis: p < 0.0001).
Having established that NK-cell distribution was different in older compared to young people, we were next interested in monitoring functional alterations. We assessed the potential capacity to produce IFN-γ and to degranulate (i.e. CD107a expression upregulation) of NK cells by incubating PBMC from young, middleaged and old individuals, with the class I negative cell line K562 ( Fig. 2A) . Cells from elderly were equally potent to produce IFN-γ and to degranulate as their younger subjects suggesting that NK cells from elderly maintain robust functional properties. Of note, functionality of NK cells from elderly resulted from the capacity, equally shared between early and late-differentiated NK cells, to both secrete IFN-γ and degranulate ( Fig. 2B and C) .
Effect of HCMV infection on human NK-cell properties
Higher frequency of terminally differentiated NK cells (NKG2C
+ ) in elderly adults is intriguing as this unique population of mature NK cells, defined with distinct function [32] was recently reported in association with HCMV infection [23, 24] . We therefore analyzed the distribution of the different subsets in individuals stratified according to HCMV status (Fig 3A-C In order to further inform on the timing of differentiated NKcell expansion in HCMV infection, we analyzed these cells in pregnant women, who encountered HCMV for the first time during pregnancy. This primary infection (PI) event led to the development of late CD57 + NK-cell subsets compared to healthy agematched HCMV-seronegative donors ( Fig. 3D ; HD− versus PI, p = 0.01 and p = 0.02, respectively). Of note, the expansion of late NK cells in seroconverting pregnant women reached the same levels as in chronically HCMV-infected donors (Fig. 3D , p = NS between HD+ and PI). In order to assess the role of HCMV persistence and/or replication in shaping NK-cell subset distribution, we studied a clinical setting with frequent HCMV reactivations. HCMV infection is the most common viral complication after solid organ transplantation [33, 34] While the main NK-cell subsets were characterized by early and intermediate differentiated phenotypes (Fig. 4A ), once again, we observed a higher proportion of NK cells with a more differentiated phenotype in the context of HCMV infection (i.e. in based on donor HCMV serostatus. Figure 5A shows the markers used to identify CD8 + memory T cells (CD27/ CD45RA/CD57) as well as their capacity to secrete IFN-γ and TNF-α upon stimulation with HCMV antigens. As expected, we observed that HCMVseropositive donors present a higher count (and percentage, data not shown) of terminally differentiated CD8 + CD57 + memory T cells than their uninfected counterparts in all groups of individuals tested (Fig. 5B) . Similarly, HCMV-seropositive control groups have a higher distribution of late CD57 + NK cells compared to HCMV-seronegative groups (Fig. 5C) and C). Of note, terminally differentiated NK cells from HCMVseropositive Yatec were amplified compared to their age-matched control groups, suggesting that both innate and adaptive immunity were highly shaped by HCMV infection ( Fig. 5B and C 5D ; r = 0.49, p < 0.0001). By looking at each group of donors, we observed a dichotomy between HCMV-seropositive and HCMV-seronegative individuals leading to a high frequency of both terminally differentiated T and NK cells only in young HCMV carriers (healthy or thymectomized) (Supporting Information Fig. 6A ,B, and D). By contrast, high frequency of late NKG2C + CD57 + NK cells can be found in elderly independently of HCMV status (Supporting Information Fig. 6C ). Furthermore, we also detected an association between HCMV-specific T-cell responsiveness and the frequency of late CD57 + NKG2C + NK cells ( Fig. 5E ; r = 0.34, p = 0.01) suggesting that innate and adaptive immunity are complementary to control HCMV latent replication.
Discussion
To date, antigen-specific NK-cell memory has been documented in mice [18, 39, 40] . In human, the memory properties of NK cells
have not yet been formally demonstrated [41, 42] . Here, we show that functional NKG2C + CD57 + NK cells expand in the context of aging and HCMV infection. We demonstrate that NKG2C + NK cells persist and can reach a high frequency in lung transplant patients (LTP) even after viral control. The preferential acquisition of CD57 on NK cells expressing NKG2C in HCMV-infected hosts suggests that antigen exposure may drive NK-cell differentiation as previously described [23, 32, 43] . Moreover, NKG2C + NK cells expand preferentially following in vitro coculture with HCMV-infected fibroblast [44] or in solid-organ transplant recipients experiencing HCMV reactivation [24] . Collectively these different studies support that NKG2C expansion is driven by the recognition of HCMV-infected cells, but the exact nature of the ligand remains unknown. The fact that a high frequency of terminally differentiated NK cells can be found in HCMV-seronegative elderly suggest that parameters related to aging (other than HCMV) could imprint the peripheral repertoire. Mechanisms could include common factors between HCMV infection and immune aging such as immune senescence, proinflammatory environment, and increased homeostatic turnover. Following transplantation using adult grafts containing mature NK cells from HCMV-seropositive donors, posttransplant HCMV reactivation represents a secondary expansion of HCMV-primed NK memory like cells. Despite the variation of viremia occurrence between our LTP, we did not observe discrete peaks of late differentiated NK cells, but rather a continuous expansion of this compartment. This is reminiscent of the CD8 + T-cell responses that are described to accumulate over time [13, 14, 45] . In contrast to other viral chronic infections, HCMV-specific T cells persist at elevated frequencies, reaching up to 50% of peripheral CD8 + T cells [13] . Therefore, in the same way, the accumulation of NKG2C + CD57 + NK cells could participate to the control of recurrent HCMV replication. Indeed, we found a positive correlation between the level of HCMV specific T cells and the frequency of NKG2C + CD57 + late differentiated NK cells enabling us to draw a parallel between NK-and T-cell responsiveness against HCMV. A number of similarities between T and NK compartment can be described: (i) HCMV is driving phenotypic differentiation [46, 47] , (ii) although HCMV-specific cells are differentiated, they are fully functional [48] [49] [50] , and (iii) late differentiated cells persist and even inflate overtime despite CD57 expression [13, 14, 45] . Interestingly, the different papers illustrating the shaping of NK cell subsets with aging [29, 30] did not take into account the impact of HCMV in the studied population despite the elevated HCMV-seroprevalence found in elderly. Here, we show, for the first time in human that the acquisition of a more mature phenotype within NK cells with aging is not restricted to HCMVseropositive individuals.
NK cells can profoundly influence the quality and magnitude of T-and B-cell responses by [51, 52] , (i) activating or killing antigen-presenting cells and regulatory T cells, (ii) modulating the proliferation and effector functions of cytotoxic T cells, (iii) by skewing helper T-cell polarization, and (iv) by enhancing B-cell activation and isotype switching. Contrarily, there is so far no knowledge about the complementary nature of NK cells and their capacity to counter balance loss of adaptive immunity. It was therefore of particular interest to follow how Yatec would cope with HCMV infection. We previously demonstrated that, in Yatec, the maintenance of a strong cellular response toward HCMV and a reduced capacity to produce new lymphocytes, can lead to a premature exhaustion of immune resources, in particular with the loss of the naïve compartment in favor of the accumulation of terminally differentiated oligoclonal CD8 + T cells mimicking the situation observed in elderly [15] . In this informative context where adaptive immunity is altered, we hypothesize that NK cells may contribute positively to the control of HCMV latency. This is in line with our observation that HCMV resulted in a marked expansion of NKG2C + CD57 + NK cells in Yatec. This suggests that NK cells have the potential to contribute alongside memory T-and B-cell responses during subsequent encounters with HCMV [26, 53] . Therefore, both innate and adaptive immunity are solicited during viral infections, such as HCMV. It has yet to be discovered how innate and adaptive immunity coordinate their fight against infection.
Materials and methods
Study subjects
Blood samples from 30 young (median = 22.19 years), 30 middleaged (median = 34.5 years), and 60 elderly (median = 84 years) healthy adults, were obtained for this study (Table 1) . We also studied Yatec (n = 61; median = 23 years). Yatec had complete removal of the thymus within 15 days after birth during open-heart surgery due to transposition of great vessels [15] . Pregnant women with primary HCMV infection were also studied (n = 10; median = 31.5 years). Diagnosis of primary HCMV infection was made on average at 14 ± 8 (mean ± SD) weeks of gestation and was based on a documented seroconversion or high titers of anti-HCMV IgM with increasing titers of anti-HCMV IgG when serostatus at the beginning of pregnancy had not been documented. LTP (n = 17) were also included in the study (median = 34 years). Posttransplant immunosuppressive treatment consisted of adapted doses of corticosteroid, calcineurin inhibitor, and a purine synthesis inhibitor, with or without depleting antibodies. Blood samples were obtained sequentially at months 2, 4, 6, 9, 12, 18, or 24 following transplantation. Regular monitoring of HCMV replication episodes was performed by quantitative PCR; viremia denoted positive virus-specific PCR in total blood from these patients. For each individual, PBMCs (isolated by density gradient centrifugation) were cryopreserved until use. HCMV serology was performed on plasma samples using a Mastazyme-CMV serology kit (Mast Diagnostics, Merseyside, UK), according to the manufacturer's recommendations. To rule out false-negative serology, we also assess specific T-cell-mediated response to HCMV immunodominant antigens by flow cytometry.
Ethics statement
All participants provided written informed consent. The study was approved by the Comité de Protection des Personnes of the Pitié Salpétrière Hospital, Paris and by the Comité d'Ethique of the Hôpital Erasme, Brussels.
Flow cytometry analysis and functional assessment
From fresh EDTA blood, absolute counts (cells per microliter) were determined using CYTO-STAT tetraCHROME kits on a FC500 cytometer (Beckman Coulter) and analyzed with Flow-Count Single Platform Method (Beckman Coulter). Directly conjugated and unconjugated antibodies were obtained from the following vendors: BD Biosciences (San Jose, CA): CD4 (HV500), CD8 (APCCy7), TNF-α (PE-Cy7), IFN-α (AF700), CD40L (PE), IL-2 (APC), CD16 (APC-H7), CD56 (PE-Cy7); Beckman Coulter (Pasadena, CA): CD3 (ECD), CD45 (KO), NKG2A (APC), CD45RA (ECD); BioLegend (San Diego, CA): CD57 (PB), CD3 (BV650); CD8 (BV650), CD27 (AF700); R&D systems (Abingdon, UK): NKG2C (PE); Milteny Biotec (Bergisch Gladbach, Germany): CD107a (VB). Staining for cell surface markers was performed with standard method as previously described [54] . Cells were analyzed on a Fortessa flow cytometer (Becton Dickinson). Data were analyzed using FlowJo v8.2 (Tree Star, Inc) and DIVA softwares (BD Biosciences).
To assess functional capacity of HCMV-specific CD8 + T cells, PBMC were stimulated with 15 amino acid long synthetic peptides (5 μM) overlapping by ten amino acids and spanning the two HCMV proteins, pp65 and IE1. After 1 h, the secretion inhibitor brefeldin A (5 μg/mL; Sigma-Aldrich) was added and the incubation was continued overnight at 37°C in a 5% CO 2 atm. Cytofix/Cytoperm TM (BD Biosciences) was used to fix/permeabilize the cells prior to staining for intracellular IFN-γ and TNF-α. The limit of detection for cytokine secretion was 0.01% in CD8 + T-cell populations based on the nonspecific production of effector molecules detected in unstimulated cells.
To assess NK cells functional capacity, frozen PBMC were cultured overnight at 37°C with IL-2, IL-12, and IL-18 (at 100 U/mL; 10 ng/mL; 100 ng/mL, respectively) and then incubated with the human erythroleukemia class I negative cell line K562 (E:T at 1:1) for 6 h as previously described [22] . Brefeldin and monensin were added after 1 h of incubation. Cells were thereafter stained for cell-surface markers including CD3, CD16, CD56, CD57, NKG2A, NKG2C, and CD107a, fixed/permeabilized and then stained for intracellular IFN-γ expression. Functional measures were corrected by subtracting background signals obtained by analyzing the same samples incubated in medium alone. Exhaustive phenotypic and functional analysis of NK cells were conducted with a beta version of the "FunkyCells ToolBox" software (www.FunkyCells.com) developed by Dr. Martin Larsen (INSERM U1135, Paris, France).
Statistical analysis
Univariate statistical analysis was performed using GraphPad prism software. Groups were compared using the nonparametric Kruskal-Wallis or Mann-Whitney tests. Wilcoxon paired test was used on lung transplant recipients for comparison between the different time points from the same patient. p values < 0.05 were considered significant.
